Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
G protein subunit alpha o1 | 0.523 | 0.808 | 0.99 |
|
disease | 0.450 | strong | 1.000 | 0 | 1 | 2013 | 2017 | ||||||||
|
calcium voltage-gated channel subunit alpha1 A | 0.489 | 0.769 | 1.00 |
|
disease | 0.430 | moderate | 1.000 | 1 | 3 | 2015 | 2018 | ||||||||
|
dynamin 1 | 0.595 | 0.692 | 1.00 |
|
disease | 0.430 | None | 1.000 | 0 | 1 | 2014 | 2018 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit alpha1 | 0.563 | 0.577 | 0.91 |
|
disease | 0.410 | moderate | 1.000 | 0 | 1 | 2013 | 2019 | ||||||||
|
heterogeneous nuclear ribonucleoprotein U | 0.575 | 0.654 | 1.00 |
|
disease | 0.400 | None | 1.000 | 1 | 4 | 2013 | 2017 | ||||||||
|
synaptic Ras GTPase activating protein 1 | 0.584 | 0.577 | 1.00 |
|
disease | 0.400 | None | 1.000 | 0 | 1 | 2012 | 2012 | ||||||||
|
syntaxin binding protein 1 | 0.532 | 0.692 | 1.00 |
|
disease | 0.200 | None | 1.000 | 0 | 6 | 2011 | 2018 | ||||||||
|
potassium voltage-gated channel subfamily Q member 2 | 0.537 | 0.654 | 1.00 |
|
disease | 0.200 | None | 1.000 | 0 | 7 | 2003 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 1 | 0.477 | 0.808 | 1.00 |
|
disease | 0.200 | None | 1.000 | 0 | 5 | 2011 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 8 | 0.510 | 0.731 | 1.00 |
|
disease | 0.200 | None | 1.000 | 0 | 5 | 2012 | 2019 | ||||||||
|
cyclin dependent kinase like 5 | 0.522 | 0.692 | 1.00 |
|
disease | 0.200 | None | 0.966 | 0 | 5 | 2007 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 2 | 0.518 | 0.731 | 1.00 |
|
disease | 0.180 | None | 1.000 | 0 | 9 | 2013 | 2019 | ||||||||
|
WW domain containing oxidoreductase | 0.453 | 0.808 | 1.2E-15 |
|
disease | 0.170 | None | 1.000 | 0 | 2 | 2015 | 2019 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit beta3 | 0.546 | 0.615 | 0.95 |
|
disease | 0.150 | None | 1.000 | 0 | 2 | 2013 | 2019 | ||||||||
|
potassium voltage-gated channel subfamily B member 1 | 0.650 | 0.462 | 1.00 |
|
disease | 0.150 | None | 1.000 | 0 | 19 | 2014 | 2019 | ||||||||
|
solute carrier family 35 member A2 | 0.525 | 0.808 | 0.72 |
|
disease | 0.140 | None | 1.000 | 0 | 1 | 2013 | 2019 | ||||||||
|
spectrin alpha, non-erythrocytic 1 | 0.601 | 0.615 | 1.00 |
|
disease | 0.130 | None | 1.000 | 0 | 1 | 2015 | 2018 | ||||||||
|
hyperpolarization activated cyclic nucleotide gated potassium channel 1 | 0.564 | 0.654 | 1.00 |
|
disease | 0.130 | None | 1.000 | 0 | 2 | 2014 | 2018 | ||||||||
|
calcium voltage-gated channel auxiliary subunit alpha2delta 2 | 0.626 | 0.615 | 1.00 |
|
disease | 0.120 | None | 0.500 | 0 | 1 | 2013 | 2019 | ||||||||
|
solute carrier family 25 member 10 | 0.666 | 0.500 | 5.9E-10 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
adaptor related protein complex 3 subunit beta 2 | 0.691 | 0.346 | 0.77 |
|
disease | 0.110 | None | 1.000 | 0 | 2 | 2016 | 2016 | ||||||||
|
protein phosphatase 3 catalytic subunit alpha | 0.568 | 0.769 | 1.00 |
|
disease | 0.110 | None | 1.000 | 0 | 1 | 2019 | 2019 | ||||||||
|
valyl-tRNA synthetase 1 | 0.711 | 0.500 | 1.8E-08 |
|
disease | 0.110 | None | 1.000 | 0 | 2 | 2019 | 2019 | ||||||||
|
UDP-glucose 6-dehydrogenase | 0.678 | 0.615 | 6.8E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2020 | 2020 | ||||||||
|
cyclin dependent kinase 2 associated protein 1 | 0.656 | 0.538 | 0.45 |
|
disease | 0.100 | None | 0 | 1 |